SK Biopharmaceuticals Co., Ltd. Reports Consolidated Earnings Results for the First Quarter of 2021
May 11, 2021 at 09:30 pm EDT
SK Biopharmaceuticals Co., Ltd. reported consolidated earnings results for the first quarter of 2021. The company reported revenue based on consolidated financial statements reached KRW 140 billion, an increase of 770% quarter-on- quarter, including milestone sales of KRW 124.5 billion. The company recorded operating profit of KRW 75.9 billion, turning a profit quarter-on- quarter.